## **Core Concept**
Meningococcal infection, caused by *Neisseria meningitidis*, is a life-threatening condition that requires immediate antibiotic treatment to prevent severe morbidity and mortality. The infection can lead to meningitis and septicemia, and its management involves prompt initiation of effective antimicrobial therapy.

## **Why the Correct Answer is Right**
The correct answer, **Ceftriaxone**, is a third-generation cephalosporin with potent activity against *Neisseria meningitidis*. It is considered a drug of choice for the treatment of meningococcal infections because it effectively crosses the blood-brain barrier, achieving high concentrations in the cerebrospinal fluid. Ceftriaxone has a broad spectrum of activity and is bactericidal against *N. meningitidis*, making it highly effective in treating this condition.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Penicillin G has limited activity against *N. meningitidis* that produce beta-lactamase, and its use could be associated with treatment failure in areas with high prevalence of resistant strains.
- **Option B:** Ciprofloxacin, a fluoroquinolone, can be used for prophylaxis against meningococcal infection but is not the first choice for treatment due to concerns about resistance and its pharmacokinetics in severe infections.
- **Option D:** Vancomycin is used in the treatment of bacterial meningitis, particularly for infections caused by Gram-positive bacteria. It is not the first-line treatment for meningococcal infections.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that in cases of suspected meningococcal infection, **prompt treatment is critical**, and the choice of antibiotic should cover the most likely pathogens. Ceftriaxone, along with supportive care, is crucial in managing patients with meningococcal disease.

## **Correct Answer:** C. Ceftriaxone.